The blood glucose monitoring system market focuses on devices and solutions that help individuals measure and manage blood sugar levels, primarily for diabetes management. It includes self-monitoring blood glucose (SMBG) devices such as glucometers, test strips, and lancets, as well as continuous glucose monitoring (CGM) systems that provide real-time insights into glucose fluctuations. Market growth is driven by the rising prevalence of diabetes worldwide, growing awareness about regular glucose monitoring, and technological advancements that enhance accuracy and user convenience. Innovations such as wearable sensors, smartphone integration, and non-invasive monitoring technologies are transforming diabetes care, enabling better disease management and improved quality of life.
The global blood glucose monitoring system market size was valued at USD 17.20 billion in 2024 and is projected to grow from USD 18.03 billion in 2025 to USD 27.73 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period. The market growth is primarily driven by the rising global prevalence of diabetes, growing awareness about glucose control, and increasing adoption of digital health technologies for real-time monitoring. North America dominated the blood glucose monitoring system market with a market share of 44.01% in 2024, owing to high diabetes prevalence, strong adoption of advanced diagnostic technologies, and robust healthcare infrastructure. The region’s leading market players, continuous innovation, and supportive government initiatives for diabetes management are expected to sustain its dominance throughout the forecast period.